TY - JOUR
T1 - Comparison of oral versus intravenous glucose exposure on plasma growth hormone levels
T2 - a crossover study in healthy volunteers
AU - Vinten, Anna Katarina
AU - Jørgensen, Nanna Thurmann
AU - Budtz-Jørgensen, Esben
AU - Klose, Marianne
AU - Andreassen, Mikkel
N1 - Publisher Copyright:
© The Author(s) 2026.
PY - 2026/2
Y1 - 2026/2
N2 - Background: Hypoglycaemia stimulates growth hormone (GH) secretion, whereas hyperglycaemia suppresses it. However, the underlying mechanisms are not fully understood, particularly the potential role of gut-derived hormones released in response to oral glucose. Aim: To investigate whether GH suppression is modulated by the route of glucose administration. Methods: A two-day intervention study in healthy volunteers. GH, insulin, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) responses during a 2-h oral glucose tolerance test (OGTT) were compared with those during a 2-h isoglycaemic intravenous (IV) glucose infusion. GH levels were analyzed using paired t-test of GH concentrations at every blood sample time point. The effect of intervention on all measured hormones were also assessed by paired t-test of Area Under the Curve (AUC). Results: 12 healthy volunteers (6 females, mean age 47.9 ± 5.4 years) were included. In 9 of the 12 subjects, IV glucose induced an early peak in plasma-GH followed by a decrease. At 20 min after glucose intake GH levels increased by 46% during IV glucose compared to a decrease of 17% during oral glucose. The biggest numerically difference in GH between oral vs IV glucose was seen at 45 min (median [range], 0.30 [0.05–1.13] vs. 0.46 [0.05–9.82] µg/l, p = 0.072). There was no difference between AUC of GH levels (p = 0.381). During IV glucose, two subjects did not reach the threshold for excluding acromegaly. Oral glucose showed significant increases compared to IV glucose for insulin (p < 0.001), GLP-1 (p = 0.002) and GIP (p < 0.001) when using paired t-test of AUC. Conclusions: Route of glucose exposure might influence the suppressive effect of glucose on GH secretion. This finding suggests that stimulation of other hormone systems may play a contributing role on the regulation of GH. The potential mechanism behind remains elusive but changes in gut-derived hormones might be of importance.
AB - Background: Hypoglycaemia stimulates growth hormone (GH) secretion, whereas hyperglycaemia suppresses it. However, the underlying mechanisms are not fully understood, particularly the potential role of gut-derived hormones released in response to oral glucose. Aim: To investigate whether GH suppression is modulated by the route of glucose administration. Methods: A two-day intervention study in healthy volunteers. GH, insulin, glucagon-like peptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) responses during a 2-h oral glucose tolerance test (OGTT) were compared with those during a 2-h isoglycaemic intravenous (IV) glucose infusion. GH levels were analyzed using paired t-test of GH concentrations at every blood sample time point. The effect of intervention on all measured hormones were also assessed by paired t-test of Area Under the Curve (AUC). Results: 12 healthy volunteers (6 females, mean age 47.9 ± 5.4 years) were included. In 9 of the 12 subjects, IV glucose induced an early peak in plasma-GH followed by a decrease. At 20 min after glucose intake GH levels increased by 46% during IV glucose compared to a decrease of 17% during oral glucose. The biggest numerically difference in GH between oral vs IV glucose was seen at 45 min (median [range], 0.30 [0.05–1.13] vs. 0.46 [0.05–9.82] µg/l, p = 0.072). There was no difference between AUC of GH levels (p = 0.381). During IV glucose, two subjects did not reach the threshold for excluding acromegaly. Oral glucose showed significant increases compared to IV glucose for insulin (p < 0.001), GLP-1 (p = 0.002) and GIP (p < 0.001) when using paired t-test of AUC. Conclusions: Route of glucose exposure might influence the suppressive effect of glucose on GH secretion. This finding suggests that stimulation of other hormone systems may play a contributing role on the regulation of GH. The potential mechanism behind remains elusive but changes in gut-derived hormones might be of importance.
KW - GIP (glucose-dependent insulinotropic polypeptide)
KW - GLP-1 (glucagon-like peptide-1)
KW - Growth hormone
KW - Incretin
KW - Insulin
KW - Intravenous glucose infusion
KW - Oral glucose tolerance test
UR - http://www.scopus.com/inward/record.url?scp=105027109534&partnerID=8YFLogxK
U2 - 10.1007/s11102-025-01633-x
DO - 10.1007/s11102-025-01633-x
M3 - Journal article
C2 - 41524818
AN - SCOPUS:105027109534
SN - 1386-341X
VL - 29
JO - Pituitary
JF - Pituitary
IS - 1
M1 - 28
ER -